Is VILACTO BIO INC (OTCMKTS:VIBI) a Buy? The Stock Reported Less Sellers..registered a decrease of 93.56% in short interest.
..Vilacto Bio Inc. operates as a biotech firm in Denmark. The company has market cap of $264,539. The firm holds a patented molecule license, known as the Lactoactive molecule for the treatment of inflammatory diseases, diabetics, psoriasis, and skin issues in various levels. It currently has negative earnings. It markets a line of skin care products, including lotions, skin care creams and gels, lip balms, foot creams and oils, and other items through its Website, vilacto.com.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.